Dysport Disease Interactions
There are 3 disease interactions with Dysport (abobotulinumtoxinA).
AbobotulinumtoxinA (applies to Dysport) lactose intolerance
Major Potential Hazard, Moderate plausibility.
Dysport (brand of abobotulinumtoxinA) may contain trace amounts of cow's milk protein. Patients known to be allergic to cow's milk protein should not be treated with this product.
References
- "Product Information. Dysport (abobotulinumtoxinA)." Tercica Inc
Botulinum toxin products (applies to Dysport) dysphagia/respiratory/neuromuscular disorders
Major Potential Hazard, Moderate plausibility. Applicable conditions: Pulmonary Impairment, Myasthenia Gravis
Treatment with botulinum toxin products, including abobotulinumtoxinA, incobotulinumtoxinA, onabotulinumtoxinA, daxibotulinumtoxinA, letibotulinumtoxinA and others can result in swallowing and breathing difficulties and in general increased neuromuscular compromise. Deaths due to severe dysphagia or respiratory failure have been reported after treatment with botulinum toxin. Care should be exercised with using these products in patients with pre- existing swallowing or respiratory disorders or peripheral motor neuropathic diseases or neuromuscular disorders (e.g., myasthenia gravis, amyotrophic lateral sclerosis), as they may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia and respiratory compromise. Patients treated with botulinum toxin may require immediate medical attention should they develop these complications. Caution is advised.
References
- "Product Information. Dysport (abobotulinumtoxinA)." Tercica Inc
- "Product Information. Botox (onabotulinumtoxinA)." Allergan Inc
- (2022) "Product Information. Xeomin (incobotulinumtoxinA)." Merz Pharmaceuticals
- (2022) "Product Information. Daxxify (daxibotulinumtoxinA)." Revance Therapeutics, Inc., 1
- (2024) "Product Information. Letybo (letibotulinumtoxinA)." Hugel Aesthetics
Botulinum toxin products (applies to Dysport) infection
Major Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Botulinum toxin products, including abobotulinumtoxinA, incobotulinumtoxinA, onabotulinumtoxinA, letibotulinumtoxinA, and others should not be used in the presence of infection at the proposed injection site(s) as it could lead to severe local or disseminated infection(s).
References
- "Product Information. Dysport (abobotulinumtoxinA)." Tercica Inc
- "Product Information. Botox (onabotulinumtoxinA)." Allergan Inc
- (2022) "Product Information. Xeomin (incobotulinumtoxinA)." Merz Pharmaceuticals
- (2022) "Product Information. Daxxify (daxibotulinumtoxinA)." Revance Therapeutics, Inc., 1
- (2024) "Product Information. Letybo (letibotulinumtoxinA)." Hugel Aesthetics
Dysport drug interactions
There are 119 drug interactions with Dysport (abobotulinumtoxinA).
More about Dysport (abobotulinumtoxinA)
- Dysport consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: skeletal muscle relaxants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.